Neurotech Historical Income Statement

NTI Stock

0.07 0.01 7.14%

Historical analysis of Neurotech International income statement accounts such as Gross Profit of 100.6 K can show how well Neurotech International performed in making a profits. Evaluating Neurotech International income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Neurotech International's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Neurotech International latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Neurotech International is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurotech International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Neurotech Income Statement Analysis

Neurotech International Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Neurotech International shareholders. The income statement also shows Neurotech investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Neurotech International Income Statement Chart

At this time, Neurotech International's Total Revenue is comparatively stable compared to the past year. Gross Profit is likely to gain to about 100.6 K in 2024, whereas Other Operating Expenses is likely to drop slightly above 202.7 K in 2024.

Selling General Administrative Other Operating Expenses Research Development Reconciled Depreciation

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Neurotech International. It is also known as Neurotech International overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Neurotech International's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Neurotech International current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurotech International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023 (projected)
Cost Of Revenue	573.5K	1.7K	7.8K
Research Development	2.6M	6.5M	5.2M

Cost Of Revenue Research Development

Neurotech International income statement Correlations

	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Interest Income	Depreciation And Amortization	Selling And Marketing Expenses	Ebitda	Net Interest Income	Reconciled Depreciation
Interest Expense		-0.21	-0.13	-0.25	-0.3	0.32	0.32	0.28	0.27	0.21	-0.34	0.32	0.13	0.31	0.21	0.9	-0.13	-0.14	0.4	-0.92	-0.01
Selling General Administrative	-0.21		-0.47	0.2	0.61	-0.42	-0.37	-0.37	0.37	-0.29	0.63	-0.62	-0.77	-0.43	-0.27	0.09	-0.1	0.09	-0.52	0.38	-0.33
Total Revenue	-0.13	-0.47		-0.16	-0.56	0.46	0.35	0.19	-0.46	0.36	-0.53	0.48	0.4	0.35	-0.06	-0.21	0.33	0.18	0.21	0.04	0.02
Gross Profit	-0.25	0.2	-0.16		0.23	-0.24	0.02	-0.24	0.19	-0.98	0.41	-0.12	0.3	-0.02	-0.2	-0.01	0.08	-0.55	-0.53	0.39	0.12
Other Operating Expenses	-0.3	0.61	-0.56	0.23		-0.96	-0.91	-0.89	0.75	-0.33	0.98	-0.98	-0.5	-0.92	-0.69	-0.14	0.4	-0.2	-0.74	0.32	-0.45
Operating Income	0.32	-0.42	0.46	-0.24	-0.96		0.94	0.9	-0.74	0.33	-0.95	0.95	0.32	0.96	0.68	0.22	-0.47	0.19	0.75	-0.29	0.45
Net Income From Continuing Ops	0.32	-0.37	0.35	0.02	-0.91	0.94		0.88	-0.62	0.06	-0.85	0.94	0.4	0.99	0.67	0.3	-0.52	-0.04	0.61	-0.25	0.39
Ebit	0.28	-0.37	0.19	-0.24	-0.89	0.9	0.88		-0.71	0.27	-0.88	0.87	0.21	0.89	0.93	0.19	-0.77	0.24	0.72	-0.25	0.45
Research Development	0.27	0.37	-0.46	0.19	0.75	-0.74	-0.62	-0.71		-0.28	0.75	-0.73	-0.34	-0.66	-0.61	0.44	0.37	-0.52	-0.61	-0.18	-0.67
Cost Of Revenue	0.21	-0.29	0.36	-0.98	-0.33	0.33	0.06	0.27	-0.28		-0.5	0.21	-0.2	0.09	0.18	-0.04	0.0	0.56	0.54	-0.36	-0.1
Total Operating Expenses	-0.34	0.63	-0.53	0.41	0.98	-0.95	-0.85	-0.88	0.75	-0.5		-0.95	-0.43	-0.87	-0.69	-0.13	0.38	-0.29	-0.82	0.4	-0.44
Income Before Tax	0.32	-0.62	0.48	-0.12	-0.98	0.95	0.94	0.87	-0.73	0.21	-0.95		0.58	0.95	0.66	0.17	-0.38	0.08	0.73	-0.33	0.51
Total Other Income Expense Net	0.13	-0.77	0.4	0.3	-0.5	0.32	0.4	0.21	-0.34	-0.2	-0.43	0.58		0.41	0.09	-0.1	0.26	-0.2	0.3	-0.25	0.46
Net Income	0.31	-0.43	0.35	-0.02	-0.92	0.96	0.99	0.89	-0.66	0.09	-0.87	0.95	0.41		0.68	0.27	-0.52	-0.04	0.66	-0.25	0.45
Income Tax Expense	0.21	-0.27	-0.06	-0.2	-0.69	0.68	0.67	0.93	-0.61	0.18	-0.69	0.66	0.09	0.68		0.13	-0.9	0.32	0.59	-0.19	0.44
Interest Income	0.9	0.09	-0.21	-0.01	-0.14	0.22	0.3	0.19	0.44	-0.04	-0.13	0.17	-0.1	0.27	0.13		-0.21	-0.35	0.11	-0.69	-0.22
Depreciation And Amortization	-0.13	-0.1	0.33	0.08	0.4	-0.47	-0.52	-0.77	0.37	0.0	0.38	-0.38	0.26	-0.52	-0.9	-0.21		-0.17	-0.34	0.01	-0.24
Selling And Marketing Expenses	-0.14	0.09	0.18	-0.55	-0.2	0.19	-0.04	0.24	-0.52	0.56	-0.29	0.08	-0.2	-0.04	0.32	-0.35	-0.17		0.39	-0.04	0.31
Ebitda	0.4	-0.52	0.21	-0.53	-0.74	0.75	0.61	0.72	-0.61	0.54	-0.82	0.73	0.3	0.66	0.59	0.11	-0.34	0.39		-0.58	0.64
Net Interest Income	-0.92	0.38	0.04	0.39	0.32	-0.29	-0.25	-0.25	-0.18	-0.36	0.4	-0.33	-0.25	-0.25	-0.19	-0.69	0.01	-0.04	-0.58		-0.12
Reconciled Depreciation	-0.01	-0.33	0.02	0.12	-0.45	0.45	0.39	0.45	-0.67	-0.1	-0.44	0.51	0.46	0.45	0.44	-0.22	-0.24	0.31	0.64	-0.12

Click cells to compare fundamentals

Neurotech International Account Relationship Matchups

Neurotech International income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Selling General Administrative	1.2M	659.8K	670.0K	710.3K	948.8K	2.4M
Total Revenue	194.6K	77.4K	206.1K	38.3K	6.0K	2.0K
Gross Profit	(1.2M)	(546.4K)	(238.7K)	(535.2K)	4.2K	(5.9K)
Other Operating Expenses	2.9M	1.3M	7.7M	4.0M	9.0M	8.8M
Operating Income	(2.7M)	(1.3M)	(7.4M)	(3.9M)	(9.0M)	(5.6M)
Net Income From Continuing Ops	(4.8M)	(1.7M)	(7.4M)	(3.4M)	(7.8M)	(5.1M)
Ebit	(2.7M)	(1.3M)	(14.9M)	(3.4M)	(9.0M)	(8.2M)
Research Development	290.1K	20.0K	5.4M	2.6M	6.5M	5.2M
Cost Of Revenue	1.4M	623.8K	444.9K	573.5K	1.7K	7.8K
Total Operating Expenses	1.5M	723.5K	7.2M	3.4M	9.0M	8.8M
Income Before Tax	(4.8M)	(1.7M)	(7.4M)	(3.9M)	(9.0M)	(8.2M)
Total Other Income Expense Net	(2.1M)	(443.5K)	55.2K	(581.4K)	(1.2M)	(2.7M)
Net Income Applicable To Common Shares	(4.8M)	(1.7M)	(7.4M)	(3.4M)	(7.8M)	(881.4K)
Net Income	(4.8M)	(1.7M)	(7.4M)	(3.4M)	(7.8M)	(5.1M)
Income Tax Expense	(2.0K)	(2.0)	(7.4M)	(569.3K)	(1.2M)	(3.2M)
Interest Income	423.7K	135.0	486.0	59.6K	158.2K	90.4K
Depreciation And Amortization	81.1K	7.4M	588.0	1.7K	583.0	553.85
Selling And Marketing Expenses	18.4K	12.5K	12.5K	10.9K	379.0	360.05
Ebitda	(1.2M)	(7.4M)	(3.4M)	(9.0M)	(8.2M)	(7.8M)
Net Interest Income	(419.5K)	(1.6K)	(883.0)	59.6K	158.2K	166.1K
Reconciled Depreciation	2.0K	81.1K	588.0	1.7K	583.0	553.85

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Neurotech Stock Analysis

When running Neurotech International's price analysis, check to measure Neurotech International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurotech International is operating at the current time. Most of Neurotech International's value examination focuses on studying past and present price action to predict the probability of Neurotech International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurotech International's price. Additionally, you may evaluate how the addition of Neurotech International to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Neurotech Historical Income Statement

About Neurotech Income Statement Analysis

Neurotech International Income Statement Chart

Other Operating Expenses

Neurotech International income statement Correlations

Neurotech International Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Neurotech International income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Neurotech Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Income	+ 0.99	Net Income From Continuing Ops
Total Operating Expenses	+ 0.98	Other Operating Expenses
Net Income	+ 0.96	Operating Income
Income Before Tax	+ 0.95	Operating Income
Net Income	+ 0.95	Income Before Tax
Net Income From Continuing Ops	+ 0.94	Operating Income

Income Before Tax	- 0.98	Other Operating Expenses
Cost Of Revenue	- 0.98	Gross Profit
Operating Income	- 0.96	Other Operating Expenses
Income Before Tax	- 0.95	Total Operating Expenses
Total Operating Expenses	- 0.95	Operating Income
Net Income	- 0.92	Other Operating Expenses